Trials / Completed
CompletedNCT00688675
Gastroesophageal Reflux Disease (GERD) Segmentation: Document How Swiss General Practitioners (GPs) Allocate Their GERD Patients to the Three GERD Patient Segments
GERD Segmentation: Document How Swiss GPs Allocate Their GERD Patients to the Three GERD Patient Segments
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,912 (estimated)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
Document how Swiss GPs allocate their GERD patients to the three GERD patient segments (according to King et al.) and how treated GERD patients are affected by their GERD treatment
Conditions
Timeline
- Start date
- 2008-02-01
- Primary completion
- 2008-08-01
- Completion
- 2008-08-01
- First posted
- 2008-06-03
- Last updated
- 2010-12-07
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT00688675. Inclusion in this directory is not an endorsement.